4月28日盘后,一向被视作医药外包(CXO)行业风向标的药明康德发布了2025年第一季度业绩报告。 财务信息显示,药明康德今年第一季度实现营收96.54亿元,同比增长20.96%;归母净利润36.72亿元,同比增长89.06%。 这是药明康德近三年来首次在第一季度交出双位数增长的“成绩单”。受此消息影响,截至4月29日收盘,药明康德A股报收60.45元,涨4.9%。 在手订单增长近五成 具体...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.